DIAGENS specializes in advanced medical diagnostic technologies, particularly in the field of genetic analysis and cytogenetics. Their flagship products include the MetaSight® Automatic Cell Microscopic Image Scanning System and the AutoVision® Intelligent Chromosome Analysis System. MetaSight® enhances the efficiency of cell image scanning, enabling rapid and precise analysis, which is crucial for timely medical interventions. AutoVision® stands out as the world's first intelligent chromosome karyotype analysis system based on deep learning, significantly improving the accuracy and speed of chromosome analysis. It automates the selection of high-quality images, optimizes karyotype images, and accurately segments overlapping chromosomes, achieving an impressive recognition accuracy rate of over 99.6%.

Additionally, DIAGENS offers the KayoFlow® Cytogenetics Automated Cell Harvesting System, which is designed for fully automated laboratory environments, enhancing operational efficiency and flexibility. Their ART Reagents and Consumables are developed to support domestic manufacturing, reducing reliance on foreign technologies. The company also emphasizes the integration of artificial intelligence in their products, such as the Medical General-Purpose Artificial Intelligence (AGI) Assistant, which enhances both work and life through multi-scenario interaction capabilities. Overall, DIAGENS is at the forefront of integrating AI and automation in medical diagnostics, significantly improving the efficiency and accuracy of genetic testing and analysis.

China

DIAGENS is a Hangzhou-based biotechnology firm, providing in-vitro diagnostic (IVD) products and other medical equipment.

DIAGENS

Company Details